Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Vaccines

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 202 articles: HTML format Text format

Single Articles

January 2012
1. O'HARA GA , Duncan CJ, Ewer KJ, Collins KA, et al
   Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector.
   J Infect Dis. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. EL SAHLY HM , Davis C, Kotloff K, Meier J, et al
   Higher Antigen Content Improves the Immune Response to 2009 H1N1 Influenza Vaccine in HIV-Infected Adults: A Randomized Clinical Trial.
   J Infect Dis. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. SCHWARZ KB
   More Lessons From the Taiwanese Hepatitis B Virus Vaccine Program.
   J Infect Dis. 2012.
   PubMed     Text format     Related articles   
   
   
   
   December 2011
4. KHURANA S , Verma N, Talaat KR, Karron RA, et al
   Immune Response Following H1N1pdm09 Vaccination: Differences in Antibody Repertoire and Avidity in Young Adults and Elderly Populations Stratified by Age and Gender.
   J Infect Dis. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. LIAO G , Li R, Li C, Sun M, et al
   Safety and Immunogenicity of Inactivated Poliovirus Vaccine Made From Sabin Strains: A Phase II, Randomized, Positive-Controlled Trial.
   J Infect Dis. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. COCHI SL , Linkins RW
   The Final Phase of Polio Eradication: New Vaccines and Complex Choices.
   J Infect Dis. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
7. WAGGIE Z , Geldenhuys H, Sutter RW, Jacks M, et al
   Randomized Trial of Type 1 and Type 3 Oral Monovalent Poliovirus Vaccines in Newborns in Africa.
   J Infect Dis. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. HAMPTON LM , Farley MM, Schaffner W, Thomas A, et al
   Prevention of Antibiotic-Nonsusceptible Streptococcus pneumoniae With Conjugate Vaccines.
   J Infect Dis. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. KIM YH , Kim JK, Kim DJ, Nam JH, et al
   Diet-Induced Obesity Dramatically Reduces the Efficacy of a 2009 Pandemic H1N1 Vaccine in a Mouse Model.
   J Infect Dis. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. BECK MA
    Influenza and Obesity: Will Vaccines and Antivirals Protect?
    J Infect Dis. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
11. BEHZAD H , Huckriede AL, Haynes L, Gentleman B, et al
    GLA-SE, a Synthetic Toll-like Receptor 4 Agonist, Enhances T-Cell Responses to Influenza Vaccine in Older Adults.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
12. SCOTT JR , Millar EV, Lipsitch M, Moulton LH, et al
    Impact of More Than a Decade of Pneumococcal Conjugate Vaccine Use on Carriage and Invasive Potential in Native American Communities.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. AMBROSE CS , Coelingh KL
    Small-Particle Aerosolization of Live Attenuated Influenza Vaccine Virus.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
14. BISCHOFF WE , Peters TR
    Reply to Ambrose and Coelingh--Small-Particle Aerosolization of Live Attenuated Influenza Vaccine Virus.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
15. SIDDIQUI F , O'Connor JR, Nagaro K, Cheknis A, et al
    Vaccination With Parenteral Toxoid B Protects Hamsters Against Lethal Challenge With Toxin A-Negative, Toxin B-Positive Clostridium difficile but Does Not Prevent Colonization.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. FRITZ R , Sabarth N, Kiermayr S, Hohenadl C, et al
    A Vero Cell-Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. DESEL C , Dorhoi A, Bandermann S, Grode L, et al
    Recombinant BCG DeltaureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses.
    J Infect Dis. 2011;204:1573-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. TSUDA Y , Safronetz D, Brown K, Lacasse R, et al
    Protective efficacy of a bivalent recombinant vesicular stomatitis virus vaccine in the Syrian hamster model of lethal ebola virus infection.
    J Infect Dis. 2011;204 Suppl 3:S1090-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. FALZARANO D , Feldmann F, Grolla A, Leung A, et al
    Single Immunization With a Monovalent Vesicular Stomatitis Virus-Based Vaccine Protects Nonhuman Primates Against Heterologous Challenge With Bundibugyo ebolavirus.
    J Infect Dis. 2011;204 Suppl 3:S1082-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. GEISBERT TW , Feldmann H
    Recombinant vesicular stomatitis virus-based vaccines against ebola and marburg virus infections.
    J Infect Dis. 2011;204 Suppl 3:S1075-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. MARZI A , Ebihara H, Callison J, Groseth A, et al
    Vesicular stomatitis virus-based ebola vaccines with improved cross-protective efficacy.
    J Infect Dis. 2011;204 Suppl 3:S1066-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. REYNARD O , Mokhonov V, Mokhonova E, Leung J, et al
    Kunjin Virus Replicon-Based Vaccines Expressing Ebola Virus Glycoprotein GP Protect the Guinea Pig Against Lethal Ebola Virus Infection.
    J Infect Dis. 2011;204 Suppl 3:S1060-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. WARFIELD KL , Aman MJ
    Advances in virus-like particle vaccines for filoviruses.
    J Infect Dis. 2011;204 Suppl 3:S1053-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. RICHARDSON JS , Abou MC, Tran KN, Kumar A, et al
    Impact of systemic or mucosal immunity to adenovirus on ad-based ebola virus vaccine efficacy in Guinea pigs.
    J Infect Dis. 2011;204 Suppl 3:S1032-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. CORTESE MM , Barskey AE, Tegtmeier GE, Zhang C, et al
    Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity.
    J Infect Dis. 2011;204:1413-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. RAYMOND J , Bradfute S, Bray M
    Filovirus infection of STAT-1 knockout mice.
    J Infect Dis. 2011;204 Suppl 3:S986-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. GUNTHER S , Feldmann H, Geisbert TW, Hensley LE, et al
    Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany.
    J Infect Dis. 2011;204 Suppl 3:S785-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
28. BANOVIC T , Yanilla M, Simmons R, Robertson I, et al
    Disseminated Varicella Infection Caused by Varicella Vaccine Strain in a Child With Low Invariant Natural Killer T Cells and Diminished CD1d Expression.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. OHMIT SE , Petrie JG, Cross RT, Johnson E, et al
    Influenza Hemagglutination-Inhibition Antibody Titer as a Correlate of Vaccine-Induced Protection.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. KIM TH , Pinkham JT, Heninger SJ, Chalabaev S, et al
    Genetic Modification of the O-Polysaccharide of Francisella tularensis Results in an Avirulent Live Attenuated Vaccine.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. LALOR MK , Floyd S, Gorak-Stolinska P, Ben-Smith A, et al
    BCG Vaccination Induces Different Cytokine Profiles Following Infant BCG Vaccination in the UK and Malawi.
    J Infect Dis. 2011;204:1075-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. IBARZ-PAVON AB , Maclennan J, Andrews NJ, Gray SJ, et al
    Changes in serogroup and genotype prevalence among carried meningococci in the United kingdom during vaccine implementation.
    J Infect Dis. 2011;204:1046-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. QUAN FS , Kim Y, Lee S, Yi H, et al
    Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice.
    J Infect Dis. 2011;204:987-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. GLASS RI
    Unexpected benefits of rotavirus vaccination in the United States.
    J Infect Dis. 2011;204:975-7.
    PubMed     Text format     Related articles   
    
    
    
    
35. LOPMAN BA , Curns AT, Yen C, Parashar UD, et al
    Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States.
    J Infect Dis. 2011;204:980-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. MEUNIER JC , Gottwein JM, Houghton M, Russell RS, et al
    Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus.
    J Infect Dis. 2011;204:1186-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. GLEZEN WP
    Broadening indications for maternal influenza vaccination.
    J Infect Dis. 2011;204:1151-3.
    PubMed     Text format     Related articles   
    
    
    
    September 2011
38. GUSTIN KM , Maines TR, Belser JA, van Hoeven N, et al
    Comparative Immunogenicity and Cross-Clade Protective Efficacy of Mammalian Cell-Grown Inactivated and Live Attenuated H5N1 Reassortant Vaccines in Ferrets.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. HALASA NB
    Make New Friends, But Keep the Old: Influenza Vaccines in Children With Cancer.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
40. CARR S , Allison KJ, Van De Velde LA, Zhang K, et al
    Safety and Immunogenicity of Live Attenuated and Inactivated Influenza Vaccines in Children With Cancer.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. BADEN LR , Blattner WA, Morgan C, Huang Y, et al
    Timing of Plasmid Cytokine (IL-2/Ig) Administration Affects HIV-1 Vaccine Immunogenicity in HIV-Seronegative Subjects.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. GOWTHAMAN U , Singh V, Zeng W, Jain S, et al
    Promiscuous Peptide of 16 kDa Antigen Linked to Pam2Cys Protects Against Mycobacterium tuberculosis by Evoking Enduring Memory T-Cell Response.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. KENNEDY JS , Gurwith M, Dekker CL, Frey SE, et al
    Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. AHMAD G , Zhang W, Torben W, Ahrorov A, et al
    Preclinical Prophylactic Efficacy Testing of Sm-p80-Based Vaccine in a Nonhuman Primate Model of Schistosoma mansoni Infection and Immunoglobulin G and E Responses to Sm-p80 in Human Serum Samples From an Area Where Schistosomiasis Is Endemic.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. STECH J , Garn H, Herwig A, Stech O, et al
    Influenza B Virus With Modified Hemagglutinin Cleavage Site as a Novel Attenuated Live Vaccine.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. LUIZA-SILVA M , Campi-Azevedo AC, Batista MA, Martins MA, et al
    Cytokine Signatures of Innate and Adaptive Immunity in 17DD Yellow Fever Vaccinated Children and Its Association With the Level of Neutralizing Antibody.
    J Infect Dis. 2011;204:873-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. JACKSON LA , Patel SM, Swamy GK, Frey SE, et al
    Immunogenicity of an Inactivated Monovalent 2009 H1N1 Influenza Vaccine in Pregnant Women.
    J Infect Dis. 2011;204:854-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. VERSTREPEN BE , Depla E, Rollier CS, Mares G, et al
    Clearance of genotype 1b hepatitis C virus in chimpanzees in the presence of vaccine-induced e1-neutralizing antibodies.
    J Infect Dis. 2011;204:837-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. HOFT DF , Babusis E, Worku S, Spencer CT, et al
    Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children.
    J Infect Dis. 2011;204:845-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. SEVER AE , Rainey JJ, Zell ER, Hennessey K, et al
    Measles elimination in the americas: a comparison between countries with a one-dose and two-dose routine vaccination schedule.
    J Infect Dis. 2011;204 Suppl 2:S748-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. PARDON F , Vilarino M, Barbero P, Garcia G, et al
    Rubella vaccination of unknowingly pregnant women during 2006 mass campaign in Argentina.
    J Infect Dis. 2011;204 Suppl 2:S745-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. SOARES RC , Siqueira MM, Toscano CM, Maia Mde L, et al
    Follow-up Study of Unknowingly Pregnant Women Vaccinated Against Rubella in Brazil, 2001-2002.
    J Infect Dis. 2011;204 Suppl 2:S729-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. SA GR , Camacho LA, Stavola MS, Lemos XR, et al
    Pregnancy outcomes following rubella vaccination: a prospective study in the state of rio de janeiro, Brazil, 2001-2002.
    J Infect Dis. 2011;204 Suppl 2:S722-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. HALKYER P , Azurduy R, Fuentes M, Van Dick AM, et al
    Putting safety first: ensuring safe vaccination practices during the 2006 rubella campaign in bolivia.
    J Infect Dis. 2011;204 Suppl 2:S718-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. CASTILLO-SOLORZANO C , Reef SE, Morice A, Vascones N, et al
    Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the americas 2001-2008.
    J Infect Dis. 2011;204 Suppl 2:S713-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. LACAPERE F , Magloire R, Danovaro-Holliday MC, Flannery B, et al
    The use of rapid coverage monitoring in the national rubella vaccination campaign, haiti 2007-2008.
    J Infect Dis. 2011;204 Suppl 2:S698-705.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. VILLAGRA E , Delgado LV, Olea A
    Enhanced surveillance for congenital rubella syndrome following mass rubella vaccination of girls and reproductive-aged women.
    J Infect Dis. 2011;204 Suppl 2:S642-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. RAINEY JJ , Danovaro-Holliday MC, Magloire R, Kananda G, et al
    Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination.
    J Infect Dis. 2011;204 Suppl 2:S616-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. SEGATTO C , Samad S, Mengue SS, Rodrigues G, et al
    Historical analysis of birth cohorts not vaccinated against rubella prior to national rubella vaccination campaign, Brazil.
    J Infect Dis. 2011;204 Suppl 2:S608-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. STREBEL PM , Gacic-Dobo M, Reef S, Cochi SL, et al
    Global use of rubella vaccines, 1980-2009.
    J Infect Dis. 2011;204 Suppl 2:S579-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. ALI M , Emch M, Park JK, Yunus M, et al
    Natural cholera infection-derived immunity in an endemic setting.
    J Infect Dis. 2011;204:912-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. SATO HK , Sanajotta AT, Moraes JC, Andrade JQ, et al
    Rubella vaccination of unknowingly pregnant women: the Sao Paulo experience, 2001.
    J Infect Dis. 2011;204 Suppl 2:S737-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. IRONS B , Morris-Glasgow V, Andrus JK, Castillo-Solorzano C, et al
    Lessons learned from integrated surveillance of measles and rubella in the Caribbean.
    J Infect Dis. 2011;204 Suppl 2:S622-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. MORICE A , Avila-Aguero ML, Salas-Peraza D, Soriano A, et al
    Approach to verify the status of measles, rubella, and congenital rubella syndrome elimination in Costa Rica.
    J Infect Dis. 2011;204 Suppl 2:S690-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. SARMIENTO H , Cobo OB, Morice A, Zapata R, et al
    Measles outbreak in Venezuela: a new challenge to postelimination surveillance and control?
    J Infect Dis. 2011;204 Suppl 2:S675-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. GALLEGOS D , Olea A, Sotomayor V, Gonzalez C, et al
    Rubella outbreaks following virus importations: the experience of Chile.
    J Infect Dis. 2011;204 Suppl 2:S669-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. ARTIMOS DE OLIVEIRA S , Bastos Camacho LA, Uzeda Barreto MC, Coca Velarde LG, et al
    Serologic status of women in an urban population in Brazil before and after rubella immunization campaign using routine screening data.
    J Infect Dis. 2011;204 Suppl 2:S664-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. MOLINA IB , Mendoza LO, Palma MA
    Congenital rubella syndrome surveillance in Honduras.
    J Infect Dis. 2011;204 Suppl 2:S637-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. URQUIJO L , Pastor D, Velandia MP, Vicari AS, et al
    Rubella and congenital rubella syndrome elimination activities: Colombia, 2005-2006.
    J Infect Dis. 2011;204 Suppl 2:S603-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. FLORES A , Villeda JA, Rodriguez-Fernandez R, Chevez AE, et al
    Advocacy and resource mobilization for rubella elimination in Guatemala.
    J Infect Dis. 2011;204 Suppl 2:S598-602.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. REEF SE , Redd SB, Abernathy E, Kutty P, et al
    Evidence used to support the achievement and maintenance of elimination of rubella and congenital rubella syndrome in the United States.
    J Infect Dis. 2011;204 Suppl 2:S593-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. MACEY JF , Tam T, Lipskie T, Tipples G, et al
    Rubella elimination, the Canadian experience.
    J Infect Dis. 2011;204 Suppl 2:S585-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. CASTILLO-SOLORZANO C , Marsigli C, Bravo-Alcantara P, Flannery B, et al
    Elimination of rubella and congenital rubella syndrome in the Americas.
    J Infect Dis. 2011;204 Suppl 2:S571-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. GROSS-GALIANO S
    Rubella and congenital rubella syndrome elimination: lessons learned for the future. Preface.
    J Infect Dis. 2011;204 Suppl 2:ii.
    PubMed     Text format     Related articles   
    
    
    
    
75. PERIAGO MR
    Elimination of rubella and congenital rubella syndrome: we did it together! Foreword.
    J Infect Dis. 2011;204 Suppl 2:i.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
76. MORENS DM , Holmes EC, Davis AS, Taubenberger JK, et al
    Global rinderpest eradication: lessons learned and why humans should celebrate too.
    J Infect Dis. 2011;204:502-5.
    PubMed     Text format     Related articles   
    
    
    
    
77. YEN C , Figueroa JR, Uribe ES, Carmen-Hernandez LD, et al
    Monovalent Rotavirus Vaccine Provides Protection Against an Emerging Fully Heterotypic G9P[4] Rotavirus Strain in Mexico.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. STRATEN PT , Andersen MH
    A Potential Role of Indoleamine 2,3-Dioxygenase-Specific T cells in Leishmania Vaccination.
    J Infect Dis. 2011;204:488-9.
    PubMed     Text format     Related articles   
    
    
    
    
79. ANDERSON KB , Gibbons RV, Edelman R, Eckels KH, et al
    Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate.
    J Infect Dis. 2011;204:442-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. HARALAMBIEVA IH , Ovsyannikova IG, Dhiman N, Kennedy RB, et al
    Common SNPs/Haplotypes in IL18R1 and IL18 Genes Are Associated With Variations in Humoral Immunity to Smallpox Vaccination in Caucasians and African Americans.
    J Infect Dis. 2011;204:433-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. WONG-CHEW RM , Garcia-Leon ML, Espinosa-Torres Torrija B, Hernandez-Perez B, et al
    Increasing the time of exposure to aerosol measles vaccine elicits an immune response equivalent to that seen in 9-month-old mexican children given the same dose subcutaneously.
    J Infect Dis. 2011;204:426-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. WESTRA TA , Rozenbaum MH, Rogoza RM, Nijman HW, et al
    Until Which Age Should Women Be Vaccinated Against HPV Infection? Recommendation Based on Cost-effectiveness Analyses.
    J Infect Dis. 2011;204:377-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. BRISSON M , van de Velde N, Franco EL, Drolet M, et al
    Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity.
    J Infect Dis. 2011;204:372-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. CASTLE PE , Zhao FH
    Population Effectiveness, Not Efficacy, Should Decide Who Gets Vaccinated Against Human Papillomavirus via Publicly Funded Programs.
    J Infect Dis. 2011;204:335-7.
    PubMed     Text format     Related articles   
    
    
    
    
85. EASTON A , Haque A, Chu K, Patel N, et al
    Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis.
    J Infect Dis. 2011;204:636-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. MORRILL JC , Peters CJ
    Mucosal Immunization of Rhesus Macaques With Rift Valley Fever MP-12 Vaccine.
    J Infect Dis. 2011;204:617-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. LASKO B , Reich D, Madan A, Roman F, et al
    Rapid Immunization Against H5N1: A Randomized Trial Evaluating Homologous and Cross-Reactive Immune Responses to AS03A-Adjuvanted Vaccination in Adults.
    J Infect Dis. 2011;204:574-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. DUNNE EF , Sternberg M, Markowitz LE, McQuillan G, et al
    Human Papillomavirus (HPV) 6, 11, 16, and 18 Prevalence Among Females in the United States--National Health and Nutrition Examination Survey, 2003-2006: Opportunity to Measure HPV Vaccine Impact?
    J Infect Dis. 2011;204:562-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
89. STAMATAKI Z , Coates S, Abrignani S, Houghton M, et al
    Immunization of Human Volunteers With Hepatitis C Virus Envelope Glycoproteins Elicits Antibodies That Cross-Neutralize Heterologous Virus Strains.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
90. LAI L , Kwa S, Kozlowski PA, Montefiori DC, et al
    Prevention of Infection by a Granulocyte-Macrophage Colony-Stimulating Factor Co-Expressing DNA/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine.
    J Infect Dis. 2011;204:164-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. LAUNAY O , Desaint C, Durier C, Loulergue P, et al
    Safety and Immunogenicity of a Monovalent 2009 Influenza A/H1N1v Vaccine Adjuvanted With AS03A or Unadjuvanted in HIV-Infected Adults: A Randomized, Controlled Trial.
    J Infect Dis. 2011;204:124-134.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. BEJON P , Cook J, Bergmann-Leitner E, Olotu A, et al
    Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01E on Blood Stage Immunity in Young Children.
    J Infect Dis. 2011;204:9-18.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. SMITH G , Michelson J, Singh R, Dabbagh A, et al
    Is there enough vaccine to eradicate measles? An integrated analysis of measles-containing vaccine supply and demand.
    J Infect Dis. 2011;204 Suppl 1:S62-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. ROTA JS , Hickman CJ, Sowers SB, Rota PA, et al
    Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission.
    J Infect Dis. 2011;204 Suppl 1:S559-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. HICKMAN CJ , Hyde TB, Sowers SB, Mercader S, et al
    Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals.
    J Infect Dis. 2011;204 Suppl 1:S549-58.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. BANKAMP B , Takeda M, Zhang Y, Xu W, et al
    Genetic characterization of measles vaccine strains.
    J Infect Dis. 2011;204 Suppl 1:S533-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. UPRETI SR , Thapa K, Pradhan YV, Shakya G, et al
    Developing rubella vaccination policy in Nepal--results from rubella surveillance and seroprevalence and congenital rubella syndrome studies.
    J Infect Dis. 2011;204 Suppl 1:S433-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. SIMONS E , Mort M, Dabbagh A, Strebel P, et al
    Strategic planning for measles control: using data to inform optimal vaccination strategies.
    J Infect Dis. 2011;204 Suppl 1:S28-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. SUGERMAN DE , Fall A, Guigui MT, N'dolie M, et al
    Preplanned national measles vaccination campaign at the beginning of a measles outbreak--sierra leone, 2009-2010.
    J Infect Dis. 2011;204 Suppl 1:S260-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. LUQUERO FJ , Pham-Orsetti H, Cummings DA, Ngaunji PE, et al
     A long-lasting measles epidemic in maroua, cameroon 2008-2009: mass vaccination as response to the epidemic.
     J Infect Dis. 2011;204 Suppl 1:S243-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. WELDEGEBRIEL GG , Gasasira A, Harvey P, Masresha B, et al
     Measles resurgence following a nationwide measles vaccination campaign in Nigeria, 2005-2008.
     J Infect Dis. 2011;204 Suppl 1:S226-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. SCOTT P , Moss WJ, Gilani Z, Low N, et al
     Measles Vaccination in HIV-Infected Children: Systematic Review and Meta-Analysis of Safety and Immunogenicity.
     J Infect Dis. 2011;204 Suppl 1:S164-78.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. FOWLKES A , Witte D, Beeler J, Audet S, et al
     Persistence of Vaccine-Induced Measles Antibody Beyond Age 12 Months: A Comparison of Response to One and Two Doses of Edmonston-Zagreb Measles Vaccine Among HIV-Infected and Uninfected Children in Malawi.
     J Infect Dis. 2011;204 Suppl 1:S149-57.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. UZICANIN A , Zimmerman L
     Field effectiveness of live attenuated measles-containing vaccines: a review of published literature.
     J Infect Dis. 2011;204 Suppl 1:S133-49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. GARRISON LP JR , Bauch CT, Bresnahan BW, Hazlet TK, et al
     Using cost-effectiveness analysis to support research and development portfolio prioritization for product innovations in measles vaccination.
     J Infect Dis. 2011;204 Suppl 1:S124-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. AABY P , Roth A, Ravn H, Napirna BM, et al
     Randomized Trial of BCG Vaccination at Birth to Low-Birth-Weight Children: Beneficial Nonspecific Effects in the Neonatal Period?
     J Infect Dis. 2011;204:245-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. MORRILL JC , Peters CJ
     Protection of MP-12-Vaccinated Rhesus Macaques Against Parenteral and Aerosol Challenge With Virulent Rift Valley Fever Virus.
     J Infect Dis. 2011;204:229-36.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. SHANN F
     The nonspecific effects of vaccines and the expanded program on immunization.
     J Infect Dis. 2011;204:182-4.
     PubMed     Text format     Related articles   
     
     
     
     
109. IRONS B , Dobbins JG
     The Caribbean experience in maintaining high measles vaccine coverage.
     J Infect Dis. 2011;204 Suppl 1:S284-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. CHANDWANI S , Beeler J, Li H, Audet S, et al
     Safety and immunogenicity of early measles vaccination in children born to HIV-infected mothers in the United States: results of Pediatric AIDS Clinical Trials Group (PACTG) protocol 225.
     J Infect Dis. 2011;204 Suppl 1:S179-89.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. 
     Proceedings of the Global Technical Consultation to assess the feasibility of measles eradication, 28-30 July 2010.
     J Infect Dis. 2011;204 Suppl 1:S1-569.
     PubMed     Text format     Related articles   
     
     
     
     
112. LEVIN A , Burgess C, Garrison LP Jr, Bauch C, et al
     Global eradication of measles: an epidemiologic and economic evaluation.
     J Infect Dis. 2011;204 Suppl 1:S98-106.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. KOEHLMOOS TP , Uddin J, Sarma H
     Impact of measles eradication activities on routine immunization services and health systems in Bangladesh.
     J Infect Dis. 2011;204 Suppl 1:S90-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. HANVORAVONGCHAI P , Mounier-Jack S, Oliveira Cruz V, Balabanova D, et al
     Impact of measles elimination activities on immunization services and health systems: findings from six countries.
     J Infect Dis. 2011;204 Suppl 1:S82-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. GRIFFITHS UK , Mounier-Jack S, Oliveira-Cruz V, Balabanova D, et al
     How can measles eradication strengthen health care systems?
     J Infect Dis. 2011;204 Suppl 1:S78-81.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. SANDERS R , Dabbagh A, Featherstone D
     Risk analysis for measles reintroduction after global certification of eradication.
     J Infect Dis. 2011;204 Suppl 1:S71-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. KEEGAN R , Dabbagh A, Strebel PM, Cochi SL, et al
     Comparing measles with previous eradication programs: enabling and constraining factors.
     J Infect Dis. 2011;204 Suppl 1:S54-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. ABERNATHY ES , Hubschen JM, Muller CP, Jin L, et al
     Status of global virologic surveillance for rubella viruses.
     J Infect Dis. 2011;204 Suppl 1:S524-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. CHOI WS , Sniadack DH, Jee Y, Go UY, et al
     Outbreak of measles in the Republic of Korea, 2007: importance of nosocomial transmission.
     J Infect Dis. 2011;204 Suppl 1:S483-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
120. SNIADACK DH , Mendoza-Aldana J, Huyen DT, Van TT, et al
     Epidemiology of a measles epidemic in Vietnam 2008-2010.
     J Infect Dis. 2011;204 Suppl 1:S476-82.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. MOSS WJ , Strebel P
     Biological feasibility of measles eradication.
     J Infect Dis. 2011;204 Suppl 1:S47-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. ZHUO J , Hoekstra EJ, Zhong G, Liu W, et al
     Innovative use of surveillance data to harness political will to accelerate measles elimination: experience from Guangxi, China.
     J Infect Dis. 2011;204 Suppl 1:S463-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. ZHUO J , Geng W, Hoekstra EJ, Zhong G, et al
     Impact of supplementary immunization activities in measles-endemic areas: a case study from Guangxi, China.
     J Infect Dis. 2011;204 Suppl 1:S455-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. MA C , An Z, Hao L, Cairns KL, et al
     Progress toward measles elimination in the People's Republic of China, 2000-2009.
     J Infect Dis. 2011;204 Suppl 1:S447-54.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. SNIADACK DH , Mendoza-Aldana J, Jee Y, Bayutas B, et al
     Progress and challenges for measles elimination by 2012 in the Western Pacific Region.
     J Infect Dis. 2011;204 Suppl 1:S439-46.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. MURHEKAR MV , Roy D, Das PK, Bose AS, et al
     Measles in rural West Bengal, India, 2005-6: low recourse to the public sector limits the use of vitamin A and the sensitivity of surveillance.
     J Infect Dis. 2011;204 Suppl 1:S427-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
127. MURHEKAR MV , Hutin YJ, Ramakrishnan R, Ramachandran V, et al
     The heterogeneity of measles epidemiology in India: implications for improving control measures.
     J Infect Dis. 2011;204 Suppl 1:S421-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
128. WIESEN E , Wannemuehler K, Goodson JL, Anand A, et al
     Stability of the age distribution of measles cases over time during outbreaks in Bangladesh, 2004-2006.
     J Infect Dis. 2011;204 Suppl 1:S414-20.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
129. 
     Proceedings of the Global Technical Consultation to assess the feasibility of measles eradication, 28-30 July 2010.
     J Infect Dis. 2011;204 Suppl 1:S4-13.
     PubMed     Text format     Related articles   
     
     
     
     
130. O'CONNOR PM , Liyanage JB, Mach O, Anand A, et al
     South-East Asia Regional update on measles mortality reduction and elimination, 2003-2008.
     J Infect Dis. 2011;204 Suppl 1:S396-402.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
131. ZIMMERMAN L , Rogalska J, Wannemuehler KA, Haponiuk M, et al
     Toward rubella elimination in Poland: need for supplemental immunization activities, enhanced surveillance, and further integration with measles elimination efforts.
     J Infect Dis. 2011;204 Suppl 1:S389-95.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
132. SIEDLER A , Mankertz A, Feil F, Ahlemeyer G, et al
     Closer to the goal: efforts in measles elimination in Germany 2010.
     J Infect Dis. 2011;204 Suppl 1:S373-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
133. ONISHCHENKO G , Ezhlova E, Gerasimova A, Tsvirkun O, et al
     Progress toward measles elimination in the Russian Federation, 2003-2009.
     J Infect Dis. 2011;204 Suppl 1:S366-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
134. MUSCAT M
     Who gets measles in Europe?
     J Infect Dis. 2011;204 Suppl 1:S353-65.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
135. CAIRNS KL , Perry RT, Ryman TK, Nandy RK, et al
     Should outbreak response immunization be recommended for measles outbreaks in middle- and low-income countries? An update.
     J Infect Dis. 2011;204 Suppl 1:S35-46.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. KHETSURIANI N , Deshevoi S, Goel A, Spika J, et al
     Supplementary immunization activities to achieve measles elimination: experience of the European Region.
     J Infect Dis. 2011;204 Suppl 1:S343-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. MARTIN R , Wassilak S, Emiroglu N, Uzicanin A, et al
     What will it take to achieve measles elimination in the World Health Organization European Region: progress from 2003-2009 and essential accelerated actions.
     J Infect Dis. 2011;204 Suppl 1:S325-34.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
138. EL SAYED N , Kandeel N, Barakat I, Moussa I, et al
     Progress toward measles and rubella elimination in Egypt.
     J Infect Dis. 2011;204 Suppl 1:S318-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
139. KAMADJEU R , Assegid K, Naouri B, Mirza IR, et al
     Measles control and elimination in Somalia: the good, the bad, and the ugly.
     J Infect Dis. 2011;204 Suppl 1:S312-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. ZAHRAEI SM , Gouya MM, Azad TM, Soltanshahi R, et al
     Successful control and impending elimination of measles in the Islamic Republic of Iran.
     J Infect Dis. 2011;204 Suppl 1:S305-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
141. JAWAD JS , Al-Sayyad AS, Sataih F, Naouri B, et al
     Toward measles elimination in Bahrain--a Middle East country experience.
     J Infect Dis. 2011;204 Suppl 1:S299-304.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
142. NAOURI B , Ahmed H, Bekhit R, Teleb N, et al
     Progress toward measles elimination in the Eastern Mediterranean Region.
     J Infect Dis. 2011;204 Suppl 1:S289-98.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
143. CASTILLO-SOLORZANO C , Marsigli C, Danovaro-Holliday MC, Ruiz-Matus C, et al
     Measles and rubella elimination initiatives in the Americas: lessons learned and best practices.
     J Infect Dis. 2011;204 Suppl 1:S279-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. CASTILLO-SOLORZANO C C , Matus CR, Flannery B, Marsigli C, et al
     The Americas: paving the road toward global measles eradication.
     J Infect Dis. 2011;204 Suppl 1:S270-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
145. GOODSON JL , Sosler S, Pasi O, Johnson T, et al
     Impact of a measles outbreak response immunization campaign: Maroua, Cameroon, 2009.
     J Infect Dis. 2011;204 Suppl 1:S252-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
146. REEF SE , Strebel P, Dabbagh A, Gacic-Dobo M, et al
     Progress toward control of rubella and prevention of congenital rubella syndrome--worldwide, 2009.
     J Infect Dis. 2011;204 Suppl 1:S24-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
147. MITIKU K , Bedada T, Masresha BG, Kegne W, et al
     Progress in measles mortality reduction in Ethiopia, 2002-2009.
     J Infect Dis. 2011;204 Suppl 1:S232-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
148. GOODSON JL , Masresha B, Dosseh A, Byabamazima C, et al
     Rubella epidemiology in Africa in the prevaccine era, 2002-2009.
     J Infect Dis. 2011;204 Suppl 1:S215-25.
     PubMed     Text format     Related articles   
     
     
     
     
149. GOODSON JL , Masresha BG, Wannemuehler K, Uzicanin A, et al
     Changing epidemiology of measles in Africa.
     J Infect Dis. 2011;204 Suppl 1:S205-14.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
150. MASRESHA BG , Fall A, Eshetu M, Sosler S, et al
     Measles mortality reduction and pre-elimination in the African region, 2001-2009.
     J Infect Dis. 2011;204 Suppl 1:S198-204.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
151. HOEKSTRA EJ , van den Ent MM, Dao H, Khalaf H, et al
     Measles supplementary immunization activities and GAVI funds as catalysts for improving injection safety in Africa.
     J Infect Dis. 2011;204 Suppl 1:S190-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
152. VAN DEN ENT MM , Brown DW, Hoekstra EJ, Christie A, et al
     Measles mortality reduction contributes substantially to reduction of all cause mortality among children less than five years of age, 1990-2008.
     J Infect Dis. 2011;204 Suppl 1:S18-23.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
153. HALL R , Jolley D
     International measles incidence and immunization coverage.
     J Infect Dis. 2011;204 Suppl 1:S158-63.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
154. CHRISTIE AS , Gay A
     The Measles Initiative: moving toward measles eradication.
     J Infect Dis. 2011;204 Suppl 1:S14-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
155. BABIGUMIRA JB , Levin A, Burgess C, Garrison LP Jr, et al
     Assessing the cost-effectiveness of measles elimination in Uganda: local impact of a global eradication program.
     J Infect Dis. 2011;204 Suppl 1:S116-23.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
156. BISHAI D , Johns B, Nair D, Nabyonga-Orem J, et al
     The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda.
     J Infect Dis. 2011;204 Suppl 1:S107-15.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
157. STREBEL PM , Cochi SL, Hoekstra E, Rota PA, et al
     A world without measles.
     J Infect Dis. 2011;204 Suppl 1:S1-3.
     PubMed     Text format     Related articles   
     
     
     
     June 2011
158. KOUTSONANOS DG , Del Pilar Martin M, Zarnitsyn VG, Jacob J, et al
     Serological Memory and Long-term Protection to Novel H1N1 Influenza Virus After Skin Vaccination.
     J Infect Dis. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
159. ARYA SC , Agarwal N
     Regarding "type 2 vaccine-derived poliovirus from patients with acute flaccid paralysis in china: current immunization strategy effectively prevented its sustained transmission".
     J Infect Dis. 2011;203:1875.
     PubMed     Text format     Related articles   
     
     
     
     
160. SCRIBA TJ , Tameris M, Mansoor N, Smit E, et al
     Dose-Finding Study of the Novel Tuberculosis Vaccine, MVA85A, in Healthy BCG-Vaccinated Infants.
     J Infect Dis. 2011;203:1832-43.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
161. CRUM-CIANFLONE NF , Wilkins K, Lee AW, Grosso A, et al
     Long-term Durability of Immune Responses After Hepatitis A Vaccination Among HIV-Infected Adults.
     J Infect Dis. 2011;203:1815-1823.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
162. LANGLEY JM , Risi G, Caldwell M, Gilderman L, et al
     Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study.
     J Infect Dis. 2011;203:1729-38.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
163. LOPEZ P , Caicedo Y, Sierra A, Tilman S, et al
     Combined, Concurrent, and Sequential Administration of Seasonal Influenza and MF59-Adjuvanted A/H5N1 Vaccines: A Phase II Randomized, Controlled Trial of Immunogenicity and Safety in Healthy Adults.
     J Infect Dis. 2011;203:1719-28.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
164. DOCKRELL HM
     Another Step Down the Development Pipeline for the Novel Tuberculosis Vaccine MVA-85A.
     J Infect Dis. 2011;203:1708-9.
     PubMed     Text format     Related articles   
     
     
     
     
165. SAMBHARA V
     Inactivated Seasonal Influenza Vaccines Increase Serum Antibodies to the Neuraminidase of Pandemic Influenza A(H1N1) 2009 Virus in an Age-Dependent Manner.
     J Infect Dis. 2011;203:1697-8.
     PubMed     Text format     Related articles   
     
     
     
     
166. KERNODLE DS
     Expectations Regarding Vaccines and Immune Therapies Directed Against Staphylococcus aureus {alpha}-Hemolysin.
     J Infect Dis. 2011;203:1692-3.
     PubMed     Text format     Related articles   
     
     
     
     
167. HUANG YS , Fisher M, Nasrawi Z, Eichenbaum Z, et al
     Defense from the group a streptococcus by active and passive vaccination with the streptococcal hemoprotein receptor.
     J Infect Dis. 2011;203:1595-601.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
168. ORLINGER KK , Hofmeister Y, Fritz R, Holzer GW, et al
     A Tick-borne Encephalitis Virus Vaccine Based on the European Prototype Strain Induces Broadly Reactive Cross-neutralizing Antibodies in Humans.
     J Infect Dis. 2011;203:1556-64.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
169. OVSYANNIKOVA IG , Vierkant RA, Pankratz VS, Jacobson RM, et al
     Human leukocyte antigen genotypes in the genetic control of adaptive immune responses to smallpox vaccine.
     J Infect Dis. 2011;203:1546-55.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
170. SABBAJ S , Pass RF, Goepfert PA, Pichon S, et al
     Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women.
     J Infect Dis. 2011;203:1534-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
171. SCHLEISS MR
     Could therapeutic vaccination of cytomegalovirus-seropositive persons prevent reinfection and congenital virus transmission?
     J Infect Dis. 2011;203:1513-6.
     PubMed     Text format     Related articles   
     
     
     
     
172. PIERSON DL , Mehta SK, Gilden D, Cohrs RJ, et al
     Varicella zoster virus DNA at inoculation sites and in saliva after Zostavax immunization.
     J Infect Dis. 2011;203:1542-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2011
173. BEALL BW , Gertz RE, Hulkower RL, Whitney CG, et al
     Shifting genetic structure of invasive serotype 19A pneumococci in the United States.
     J Infect Dis. 2011;203:1360-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
174. OHFUJI S , Fukushima W, Deguchi M, Kawabata K, et al
     Immunogenicity of a Monovalent 2009 Influenza A (H1N1) Vaccine Among Pregnant Women: Lowered Antibody Response by Prior Seasonal Vaccination.
     J Infect Dis. 2011;203:1301-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
175. DUDEK TE , Torres-Lopez E, Crumpacker C, Knipe DM, et al
     Evidence for differences in immunologic and pathogenesis properties of herpes simplex virus 2 strains from the United States and South Africa.
     J Infect Dis. 2011;203:1434-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2011
176. LI JZ , Brumme ZL, Brumme CJ, Wang H, et al
     Factors Associated With Viral Rebound in HIV-1-Infected Individuals Enrolled in a Therapeutic HIV-1 gag Vaccine Trial.
     J Infect Dis. 2011;203:976-983.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
177. GILBERT PB , Berger JO, Stablein D, Becker S, et al
     Statistical Interpretation of the RV144 HIV Vaccine Efficacy Trial in Thailand: A Case Study for Statistical Issues in Efficacy Trials.
     J Infect Dis. 2011;203:969-75.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
178. WASSILAK S , Pate MA, Wannemuehler K, Jenks J, et al
     Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population.
     J Infect Dis. 2011;203:898-909.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
179. SPEARMAN P , Lally MA, Elizaga M, Montefiori D, et al
     A Trimeric, V2-Deleted HIV-1 Envelope Glycoprotein Vaccine Elicits Potent Neutralizing Antibodies but Limited Breadth of Neutralization in Human Volunteers.
     J Infect Dis. 2011;203:1165-1173.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
180. HAUT LH , Ratcliffe S, Pinto AR, Ertl H, et al
     Effect of preexisting immunity to adenovirus on transgene product-specific genital T cell responses on vaccination of mice with a homologous vector.
     J Infect Dis. 2011;203:1073-81.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
181. HEIJMANS S , De Meulemeester M, Reynders P, Giet D, et al
     Immunogenicity Profile of a 3.75-{micro}g Hemagglutinin Pandemic rH5N1 Split Virion AS03A-Adjuvanted Vaccine in Elderly Persons: A Randomized Trial.
     J Infect Dis. 2011;203:1054-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
182. GORDON SN , Cecchinato V, Andresen V, Heraud JM, et al
     Smallpox vaccine safety is dependent on T cells and not B cells.
     J Infect Dis. 2011;203:1043-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
183. BRAY M
     Understanding smallpox vaccination.
     J Infect Dis. 2011;203:1037-9.
     PubMed     Text format     Related articles   
     
     
     
     
184. NATHANSON N
     Eradication of poliovirus: fighting fire with fire.
     J Infect Dis. 2011;203:889-90.
     PubMed     Text format     Related articles   
     
     
     
     March 2011
185. LEDGERWOOD JE , Pierson TC, Hubka SA, Desai N, et al
     A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial.
     J Infect Dis. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
186. TYRRELL GJ
     The Changing Epidemiology of Streptococcus pneumoniae Serotype 19A Clonal Complexes.
     J Infect Dis. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
187. SRIKRAM A , Zhang K, Bartpho T, Lo M, et al
     Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant.
     J Infect Dis. 2011;203:870-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
188. PETRIE JG , Ohmit SE, Johnson E, Cross RT, et al
     Efficacy Studies of Influenza Vaccines: Effect of End Points Used and Characteristics of Vaccine Failures.
     J Infect Dis. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
189. BELSHE RB , Frey SE, Graham I, Mulligan MJ, et al
     Safety and Immunogenicity of Influenza A H5 Subunit Vaccines: Effect of Vaccine Schedule and Antigenic Variant.
     J Infect Dis. 2011;203:666-673.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
190. GOEPFERT PA , Elizaga ML, Sato A, Qin L, et al
     Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles.
     J Infect Dis. 2011;203:610-619.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
191. ALTMANN S , Brandt CR, Murphy CJ, Patnaikuni R, et al
     Evaluation of therapeutic interventions for vaccinia virus keratitis.
     J Infect Dis. 2011;203:683-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
192. FITZGERALD DW , Janes H, Robertson M, Coombs R, et al
     An Ad5-Vectored HIV-1 Vaccine Elicits Cell-mediated Immunity but does not Affect Disease Progression in HIV-1-infected Male Subjects: Results From a Randomized Placebo-Controlled Trial (The Step Study).
     J Infect Dis. 2011;203:765-772.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
193. ALTFELD M , Goulder PJ
     The STEP Study Provides a Hint That Vaccine Induction of the Right CD8+ T Cell Responses Can Facilitate Immune Control of HIV.
     J Infect Dis. 2011;203:753-5.
     PubMed     Text format     Related articles   
     
     
     
     February 2011
194. BUCASAS KL , Franco LM, Shaw CA, Bray MS, et al
     Early Patterns of Gene Expression Correlate With the Humoral Immune Response to Influenza Vaccination in Humans.
     J Infect Dis. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
195. GARCIA F , Climent N, Assoumou L, Gil C, et al
     A Therapeutic Dendritic Cell-Based Vaccine for HIV-1 Infection.
     J Infect Dis. 2011;203:473-478.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
196. KIMBERLIN DW
     Control of varicella disease, version 2.0.
     J Infect Dis. 2011;203:297-9.
     PubMed     Text format     Related articles   
     
     
     
     January 2011
197. FELLAY J , Frahm N, Shianna KV, Cirulli ET, et al
     Host Genetic Determinants of T Cell Responses to the MRKAd5 HIV-1 gag/pol/nef Vaccine in the Step Trial.
     J Infect Dis. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
198. DE VRIES-SLUIJS TE , Hansen BE, van Doornum GJ, Kauffmann RH, et al
     A Randomized Controlled Study of Accelerated Versus Standard Hepatitis B Vaccination in HIV-Positive Patients.
     J Infect Dis. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
199. CHEN GL , Min JY, Lamirande EW, Santos C, et al
     Comparison of a Live Attenuated 2009 H1N1 Vaccine with Seasonal Influenza Vaccines against 2009 Pandemic H1N1 Virus Infection in Mice and Ferrets.
     J Infect Dis. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
200. TALBOT HK , Griffin MR, Chen Q, Zhu Y, et al
     Effectiveness of Seasonal Vaccine in Preventing Confirmed Influenza-Associated Hospitalizations in Community Dwelling Older Adults.
     J Infect Dis. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
201. SMITH HL , Monath TP, Pazoles P, Rothman AL, et al
     Development of Antigen-Specific Memory CD8+ T Cells Following Live-Attenuated Chimeric West Nile Virus Vaccination.
     J Infect Dis. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
202. DESSELBERGER U , Huppertz HI
     Immune responses to rotavirus infection and vaccination and associated correlates of protection.
     J Infect Dis. 2011;203:188-95.
     PubMed     Text format     Related articles   
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: